Thorotrast Mesothelioma, 2

The clinical manifestation was a serosal effusion which required weekly ascites puncture until therapy with intraperitoneal bleomycin was initiated.

So cute coloring pages. There have also been reports linking mesothelioma to injections of thorium dioxide thorotrast. This radioactive material was used by doctors for certain x ray tests until the 1950s. Usually thorium dioxide called thorotrast.

This chemical was used until the 1950s in some x ray tests. Thorotrast was found to cause cancers so it has not been used for many decades. Mesothelioma is cancer of the mesothelium a membrane that lines the inside of the bodys cavities such as the abdomen or chest.

The latter treatment led to a significant reduction of. It is used by doctors in the process of chest x rays. The injection of thorotrast has also been closely linked with the development of mesothelioma.

There was no history of exposure to asbestos. Thorotrast can lead to some other serious health problems. There was no history of exposure to asbestos.

In rare cases mesothelioma has also been associated with irradiation intrapleural thorium dioxide thorotrast and inhalation of other fibrous silicates such as erionite. Eleven years before death the right kidney had to be removed for hydronephrosis due to fibrous stenosis of the pyeloureteral junction because of thorium dioxide deposits. However mesothelioma has been reported in some individuals without any known exposure to asbestos.

A case of a malignant peritoneal mesothelioma in a 63 year old male patient with a history of exposure to thorotrast in 1945 is presented. In a previous registry based survey of 999 patients injected with alpha emitting 232tho2 thorotrast we identified elevated risks for lung carcinoma and malignant mesothelioma. In some cases researchers found that injecting thorium dioxide into an individuals body is also a reason for mesothelioma.

Additionally a material called thorium dioxide or thorotrast was used in medical imaging around that time period. The clinical manifestation was a serosal effusion which required weekly ascites puncture until therapy with intraperitoneal bleomycin was initiated. Reported is a 59yearold patient who died of a peritoneal mesothelioma 36 years after contamination with thorotrast of the peritoneal cavity during cholangiography at cholecystectomy.

A case of a malignant peritoneal mesothelioma in a 63 year old male patient with a history of exposure to thorotrast in 1945 is presented. Since injected thorotrast is retained lifelong mostly in liver spleen and lymph nodes the mesothelial surfaces of these organs are constantly irradiated.